
Novo Nordisk slashing price of weight-loss drug to $499 a month to uninsured following rival's move
Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive dynamic of the US obesity drug market. The move comes just over …